Gene Therapy Regenerates Diseased Liver in Pigs (1 of 3) (IMAGE)
Caption
Schematic of the steps involved in ex vivo gene therapy in FAH-deficient (Fah?/?) pigs, a model of a metabolic liver disorder known as hereditary tyrosinemia type 1. This material relates to a paper that appeared in the July 27, 2016, issue of Science Translational Medicine, published by AAAS. The paper, by R.D. Hickey at Mayo Clinic in Rochester, MN, and colleagues was titled, 'Curative ex vivo liver-directed gene therapy in a pig model of hereditary tyrosinemia type 1.'
Credit
Hickey <i>et al., Science Translational Medicine</i> (2016)
Usage Restrictions
Please cite the owner of the material when publishing. This material may be freely used by reporters as part of news coverage, with proper attribution. Non-reporters must contact <i>Science</i> for permission.
License
Licensed content